Global patent index - EP 0973923 A1

EP 0973923 A1 2000-01-26 - IMPROVED ASSAYS FOR $g(b)-AMYLOID PROCESSING

Title (en)

IMPROVED ASSAYS FOR $g(b)-AMYLOID PROCESSING

Title (de)

VERBESSERTE TESTS FÜR DIE BETA-AMYLOID PROZESSIERUNG

Title (fr)

DOSAGES PERFECTIONNES POUR L'ELABORATION DE LA PROTEINE $g(b)-AMYLOIDE

Publication

EP 0973923 A1 (EN)

Application

EP 98904812 A

Priority

  • US 9801899 W
  • US 80497197 A
  • US 82573797 A
  • US 90429697 A

Abstract (en)

[origin: WO9837215A1] The invention relates to the design, construction and use of eukaryotic cell lines useful in the identification of inhibitors of beta -amyloid processing. More specifically, the invention relates to in vitro assays capable of identifying or quantifying a 4.2 kDa beta -amyloid protein. The present invention also provides for DNA and protein molecules for the design, construction and use of eukaryotic cell lines useful in the identification of inhibitors of beta -amyloid processing.

IPC 1-7 (main, further and additional classification)

C12N 15/85; C07K 14/47; C07K 16/18; C12N 5/10; C12N 15/12; G01N 33/68

IPC 8 full level (invention and additional information)

G01N 33/50 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/08 (2006.01); G01N 33/15 (2006.01)

CPC (invention and additional information)

C07K 14/4711 (2013.01)

Citation (search report)

See references of WO 9837215A1

Designated contracting state (EPC)

CH DE FR GB IT LI

EPO simple patent family

WO 9837215 A1 19980827; AU 6260098 A 19980909; EP 0973923 A1 20000126; JP 2001512973 A 20010828

INPADOC legal status

2008-12-24 [18W] WITHDRAWN

- Effective date: 20081120

2006-11-02 [RAP1] TRANSFER OF RIGHTS OF AN EP APPLICATION

- Owner name: AVENTIS PHARMACEUTICALS, INC.

2006-11-02 [RAP1] TRANSFER OF RIGHTS OF AN EP APPLICATION

- Owner name: SCIOS INC.

2003-11-05 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20030923

2000-07-26 [RTI1] TITLE (CORRECTION)

- Free Format Text: IMPROVED ASSAYS FOR BETA-AMYLOID PROCESSING

2000-05-17 [RAP1] TRANSFER OF RIGHTS OF AN EP APPLICATION

- Owner name: AVENTIS PHARMACEUTICALS INC.

2000-05-17 [RAP1] TRANSFER OF RIGHTS OF AN EP APPLICATION

- Owner name: SCIOS INC.

2000-01-26 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 19990823

2000-01-26 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): CH DE FR GB IT LI